For pancreatic cancer, the probability of distant metastasis can help choose the best course
of treatment. The aim of this study is to establish the efficacy of hydroxyproline as a …

BACKGROUND Patients with malignant tumors frequently exhibit hyperactivation of the
coagulation system and secondary increased fibrinolytic activity. Fibrinogen and D-dimer …

Abstract Background/Purpose Laparoscopic pancreaticoduodenectomy (PD) with major vein
resection is a challenging procedure. Herein, we evaluated the feasibility and safety of …

Background Few studies have examined the relation between extent of vascular resection
and morbidity following pancreaticoduodenectomy (PD) with vein resection (PDVR) …

Purpose Raf kinase inhibitor protein (RKIP) is a tumor suppressor that inhibits cell growth
and metastasis of malignant tumors. Pancreatic cancer is a leading cause of cancer death …

Background Patient and health system determinants of outcomes following pancreatic
cancer resection, particularly the relative importance of hospital and surgeon volume, are …

Purpose Extended pancreatectomy aimed at R0 resection of pancreatic tumors with
adjacent vessel and organ involvement may be the only option for cure. This study was done …

Purpose The index composed of preoperative lymphocytes, albumin, and neutrophils
(LANR), a new composite score based on inflammatory response and nutritional status, has …

Background The current staging system for pancreatic ductal adenocarcinoma (PDAC)
includes information about size and local extension of the primary tumor (T stage). The value …

Background Borderline resectable pancreatic cancer may require extended resections in
order to achieve tumor-free margins, especially in the case of up-front resections, but it is …